ReviewExperimental & molecular medicine2024

Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease.

Byung Jo Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.